Novel 1,5‐Benzodiazepines as CCK‐B Ligands. Effect of Aryl‐Carbamic Substituents at the C‐3 Position Together with Halogen Substitution on the Benzo‐Fused Ring

Abstract

Abstract The synthesis and biological evaluation as potential CCK‐B receptor ligands of a number of 1‐isopentyl‐3‐aryloxycarbamoyl‐5‐aryl‐1,5‐benzodiazepines substituted with halogen atoms on the benzo‐fused ring is here briefly discussed.